UChicago Medicine, a leading academic health system, exemplifies innovation across clinical care, research and community engagement. Since 2023, the system has expanded its footprint through a joint venture in Chicago’s western suburbs with Altamonte Springs, Fla.-based AdventHealth and by opening a 130,000-square-foot multispecialty center in Crown Point, Ind., bringing specialized care closer to diverse communities. With a deep commitment to health equity, UChicago Medicine operates a violence recovery program that connects trauma victims to community support, and is partnering with the City Colleges of Chicago to launch a new clinical lab and learning center aimed at creating jobs and career pipelines. The system is also a pioneer in the ethical application of AI, having implemented health tech company Abridge’s ambient AI platform to reduce clinician burnout and improve documentation for over 600 providers, with systemwide expansion underway. UChicago’s Duchossois Family Institute recently debuted the first clinical-grade microbiome drug manufacturing facility at an academic institution, supporting cutting-edge research into gut health and personalized medicine. Further cementing its leadership, UChicago Medicine is building Illinois’ first freestanding cancer care and research facility, the AbbVie Foundation Cancer Pavilion, which will integrate clinical treatment and translational science in a 575,000-square-foot space upon opening in 2027.
